Important amino acids for the function of the human MT1 melatonin receptor.

Standard

Important amino acids for the function of the human MT1 melatonin receptor. / Kokkola, Tarja; Foord, Steven M; Watson, Marie-Ange; Vakkuri, Olli; Laitinen, Jarmo T.

in: BIOCHEM PHARMACOL, Jahrgang 65, Nr. 9, 9, 2003, S. 1463-1471.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Kokkola, T, Foord, SM, Watson, M-A, Vakkuri, O & Laitinen, JT 2003, 'Important amino acids for the function of the human MT1 melatonin receptor.', BIOCHEM PHARMACOL, Jg. 65, Nr. 9, 9, S. 1463-1471. <http://www.ncbi.nlm.nih.gov/pubmed/12732358?dopt=Citation>

APA

Kokkola, T., Foord, S. M., Watson, M-A., Vakkuri, O., & Laitinen, J. T. (2003). Important amino acids for the function of the human MT1 melatonin receptor. BIOCHEM PHARMACOL, 65(9), 1463-1471. [9]. http://www.ncbi.nlm.nih.gov/pubmed/12732358?dopt=Citation

Vancouver

Kokkola T, Foord SM, Watson M-A, Vakkuri O, Laitinen JT. Important amino acids for the function of the human MT1 melatonin receptor. BIOCHEM PHARMACOL. 2003;65(9):1463-1471. 9.

Bibtex

@article{b98e5e7d32cf4205b4a175ac85372a35,
title = "Important amino acids for the function of the human MT1 melatonin receptor.",
abstract = "Models of G protein-coupled melatonin receptor structure suggest that ligand recognition occurs in a binding pocket formed by transmembrane helices III, V and VII. Constitutively active mutations in G protein-coupled receptors have revealed that transmembrane helix III/intracellular loop 2 interface and transmembrane domain VI are critical regions in receptor activation. In this study, nine site-directed mutants of the human MT1 melatonin receptor were created to test the importance of specific amino acids in these regions in ligand recognition and receptor activation events. We analyzed ligand binding, G protein activation and subcellular localization of MT1 receptors transiently expressed in COS-7 cells. Receptor ELISA was employed to study expression levels of N-terminally HA epitope tagged wild-type and mutant MT1 receptors. Mutations in histidine H195 (His(5.46)) in transmembrane domain V reduced receptor affinity for 2-[125I]iodomelatonin. Several other mutants had diminished expression on the plasma membrane. Amino acids M107 (Met(3.32)) in transmembrane domain III and S280 (Ser(7.46)) in transmembrane domain VII were found not to participate in ligand recognition in human MT1 receptor. Constitutive activity was not obtained with mutations in N124 (Asn(3.49)) or P253 (Pro(6.50)). These mutants failed to bind 2-[125I]iodomelatonin and had reduced expression levels. The need to upgrade current melatonin receptor models has become evident. Several important amino acids for the human MT1 melatonin receptor function were revealed in the current study, with effects of mutations ranging from slightly reduced affinity or efficacy to complete loss of function.",
author = "Tarja Kokkola and Foord, {Steven M} and Marie-Ange Watson and Olli Vakkuri and Laitinen, {Jarmo T}",
year = "2003",
language = "Deutsch",
volume = "65",
pages = "1463--1471",
journal = "BIOCHEM PHARMACOL",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "9",

}

RIS

TY - JOUR

T1 - Important amino acids for the function of the human MT1 melatonin receptor.

AU - Kokkola, Tarja

AU - Foord, Steven M

AU - Watson, Marie-Ange

AU - Vakkuri, Olli

AU - Laitinen, Jarmo T

PY - 2003

Y1 - 2003

N2 - Models of G protein-coupled melatonin receptor structure suggest that ligand recognition occurs in a binding pocket formed by transmembrane helices III, V and VII. Constitutively active mutations in G protein-coupled receptors have revealed that transmembrane helix III/intracellular loop 2 interface and transmembrane domain VI are critical regions in receptor activation. In this study, nine site-directed mutants of the human MT1 melatonin receptor were created to test the importance of specific amino acids in these regions in ligand recognition and receptor activation events. We analyzed ligand binding, G protein activation and subcellular localization of MT1 receptors transiently expressed in COS-7 cells. Receptor ELISA was employed to study expression levels of N-terminally HA epitope tagged wild-type and mutant MT1 receptors. Mutations in histidine H195 (His(5.46)) in transmembrane domain V reduced receptor affinity for 2-[125I]iodomelatonin. Several other mutants had diminished expression on the plasma membrane. Amino acids M107 (Met(3.32)) in transmembrane domain III and S280 (Ser(7.46)) in transmembrane domain VII were found not to participate in ligand recognition in human MT1 receptor. Constitutive activity was not obtained with mutations in N124 (Asn(3.49)) or P253 (Pro(6.50)). These mutants failed to bind 2-[125I]iodomelatonin and had reduced expression levels. The need to upgrade current melatonin receptor models has become evident. Several important amino acids for the human MT1 melatonin receptor function were revealed in the current study, with effects of mutations ranging from slightly reduced affinity or efficacy to complete loss of function.

AB - Models of G protein-coupled melatonin receptor structure suggest that ligand recognition occurs in a binding pocket formed by transmembrane helices III, V and VII. Constitutively active mutations in G protein-coupled receptors have revealed that transmembrane helix III/intracellular loop 2 interface and transmembrane domain VI are critical regions in receptor activation. In this study, nine site-directed mutants of the human MT1 melatonin receptor were created to test the importance of specific amino acids in these regions in ligand recognition and receptor activation events. We analyzed ligand binding, G protein activation and subcellular localization of MT1 receptors transiently expressed in COS-7 cells. Receptor ELISA was employed to study expression levels of N-terminally HA epitope tagged wild-type and mutant MT1 receptors. Mutations in histidine H195 (His(5.46)) in transmembrane domain V reduced receptor affinity for 2-[125I]iodomelatonin. Several other mutants had diminished expression on the plasma membrane. Amino acids M107 (Met(3.32)) in transmembrane domain III and S280 (Ser(7.46)) in transmembrane domain VII were found not to participate in ligand recognition in human MT1 receptor. Constitutive activity was not obtained with mutations in N124 (Asn(3.49)) or P253 (Pro(6.50)). These mutants failed to bind 2-[125I]iodomelatonin and had reduced expression levels. The need to upgrade current melatonin receptor models has become evident. Several important amino acids for the human MT1 melatonin receptor function were revealed in the current study, with effects of mutations ranging from slightly reduced affinity or efficacy to complete loss of function.

M3 - SCORING: Zeitschriftenaufsatz

VL - 65

SP - 1463

EP - 1471

JO - BIOCHEM PHARMACOL

JF - BIOCHEM PHARMACOL

SN - 0006-2952

IS - 9

M1 - 9

ER -